Surfactant protein D/anti-Fc receptor bifunctional proteins as a tool to enhance host defence

被引:1
作者
Breij, Esther C. W. [1 ]
Batenburg, Joseph J. [1 ]
机构
[1] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Sci, NL-3584 CM Utrecht, Netherlands
关键词
broad-spectrum antimicrobial therapy; Fc receptors; host defence; pathogen targeting; surfactant protein D;
D O I
10.1517/14712598.8.4.409
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Background: Drug-resistant pathogens are an increasing threat, particularly for hospitalised patients. In search of a new approach in pathogen targeting, we developed bifunctional proteins that combine broad spectrum pathogen recognition with efficient targeting to phagocytes. Pathogen recognition is provided by a recombinant fragment of surfactant protein D (rfSP-D) while targeting to phagocytic cells is accomplished by coupling rfSP-D to F(ab') fragments directed against Fc alpha receptor 1 (Fc alpha R1) or Fc gamma receptor 1 (Fc gamma R1). Fc alpha R1 and Fc gamma R1 are expressed on myeloid cells, and induce rapid internalisation of particles after crosslinking. Objective/methods: In this review we discuss the roles of SP-D and Fc receptors in host defence as a rationale for rfSP-D/anti-FcR bifunctional proteins. Furthermore we summarise the available data on rfSP-D/anti-FcR proteins as well as opportunities and considerations for future use of such bifunctional proteins. Results/conclusion: rfSP-D/anti-FcR bifunctional proteins could be of great value for the treatment of a variety of infectious diseases. The focus in the near future should be on proof-of-principle by testing the bifunctional proteins in different mouse models of infectious disease.
引用
收藏
页码:409 / 419
页数:11
相关论文
共 79 条
[1]
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours [J].
Aapro, M. S. ;
Cameron, D. A. ;
Pettengell, R. ;
Bohlius, J. ;
Crawford, J. ;
Ellis, M. ;
Kearney, N. ;
Lyman, G. H. ;
Tjan-Heijnen, V. C. ;
Walewski, J. ;
Weber, D. C. ;
Zielinski, C. .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) :2433-2453
[2]
Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus [J].
Allen, MJ ;
Voelker, DR ;
Mason, RJ .
INFECTION AND IMMUNITY, 2001, 69 (04) :2037-2044
[3]
Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice [J].
Atochina, EN ;
Gow, AJ ;
Beck, JM ;
Haczku, A ;
Inch, A ;
Kadire, H ;
Tomer, Y ;
Davis, C ;
Preston, AM ;
Poulain, F ;
Hawgood, S ;
Beers, MF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08) :1528-1539
[4]
Pulmonary surfactant proteins a and D directly suppress CD3+/CD4+ cell function:: Evidence for two shared mechanisms1 [J].
Borron, PJ ;
Mostaghel, EA ;
Doyle, C ;
Walsh, ES ;
McHeyzer-Williams, MG ;
Wright, JR .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5844-5850
[5]
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia [J].
Cheung, Chung-Lam ;
Rayner, Jane M. ;
Smith, Gavin J. D. ;
Wang, Pui ;
Naipospos, T. S. P. ;
Zhang, Jinxia ;
Yuen, Kwok-Yung ;
Webster, Robert G. ;
Peiris, J. S. Malik ;
Guan, Yi ;
Chen, Honglin .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (12) :1626-1629
[6]
Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids [J].
Chiba, H ;
Pattanajitvilai, S ;
Evans, AJ ;
Harbeck, RJ ;
Voelker, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :20379-20385
[7]
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema [J].
Clark, H ;
Reid, K .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (11) :981-984
[8]
Structural requirements for SP-D function in vitro and in vivo:: Therapeutic potential of recombinant SP-D [J].
Clark, H ;
Reid, KBM .
IMMUNOBIOLOGY, 2002, 205 (4-5) :619-631
[9]
Surfactant protein D reduces alveolar macrophage apoptosis in vivo [J].
Clark, H ;
Palaniyar, N ;
Strong, P ;
Edmondson, J ;
Hawgood, S ;
Reid, KBM .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :2892-2899
[10]
CROUCH E, 1994, J BIOL CHEM, V269, P17311